CLARITY News and Research

RSS

The lipid-exchanged, anatomically rigid, imaging/immunostaining compatible, tissue hydrogel (CLARITY) method was initially designed in 2013 by Chung and Deisseroth at the Stanford University School of Medicine. Using this process, post-mortem organs can be labeled for proteins and nucleic acids, enabling analysis of intact samples to create detailed 3D images.

World's largest single-site study maps brain changes under psilocybin

A landmark five-year study by Monash University has found psychedelics reorganise brain patterns, giving clinicians powerful new insights into their therapeutic potential.

19 Aug 2026

Women with type 2 diabetes saw striking changes after 24 weeks of this eating pattern

A 24-week randomized trial found that a lacto-vegetarian diet combined with 14-hour time-restricted eating improved glycemic control, insulin resistance, body weight, and lipid measures in Indian women with type 2 diabetes. The combined, nutritionist-supported intervention was generally well tolerated, but its individual dietary and fasting effects cannot be separated and longer-term studies are needed.

18 Aug 2026

Fluctuating work hours increase health risks for workers

Workers who juggle volatile work hours that change from week to week may experience adverse health effects that impact their ability to work, although the limitations vary by gender, say researchers at the University of Illinois Urbana-Champaign who conducted a recent study.

18 Aug 2026

Choosing the right benchtop fluorescence microscope for your lab

Learn what matters when comparing benchtop fluorescence microscopes, from confocal and widefield imaging to software.

From Oxford Instruments - Life Sciences 17 Aug 2026

New machine learning model improves accuracy of prenatal genetic testing

Advances in genome sequencing are giving more families access to prenatal genetic testing and new information about an unborn baby's health, including whether genetic changes may link to a neurodevelopmental condition.

11 Aug 2026

Leica Biosystems enables faster cancer diagnoses through multiple digital pathology FDA clearances, including industry-first AI-assisted quality control software

Leica Biosystems introduces AI-driven quality control in digital pathology, streamlining workflows and enhancing diagnostic accuracy for better patient care.

From Leica Biosystems 11 Aug 2026

Explainable AI helps predict dangerous bleeding after severe heart attacks

Researchers at Indiana University School of Medicine have developed and tested a six-point scoring system that can help identify patients at high risk of internal bleeding in damaged heart muscle after a severe heart attack using explainable artificial intelligence (XAI).

9 Aug 2026

Study links higher body fat to lower sperm counts despite normal BMI

Among 1,058 Danish men, higher body fat percentage was associated with lower total sperm count and altered reproductive hormone levels, but not testicular volume. Body fat percentage showed stronger links with several semen measures than BMI or waist-to-height ratio, with the sperm-count association strengthening among men with normal BMI.

2 Aug 2026

Lanthanide carriers advance next generation biomedical imaging and theranostics

Lanthanide carriers could help define the next generation of biomedical imaging and fast-track the emerging field of theranostics-approaches that link diagnostic imaging with treatment selection, delivery, or monitoring.

30 Jul 2026

Amyloid beta misfolding predicts Alzheimer's years before symptoms appear

Widely used Alzheimer’s biomarker P-tau 217 reliably detects the disease only at the clinical stage. The protein misfolding of amyloid beta indicates an increased risk years earlier.

27 Jul 2026

AI mental health chatbots feel empathetic, but safety evidence still lags

Immune dysregulation may contribute to depression, schizophrenia, bipolar disorder, and anxiety through chronic inflammation, altered neuroimmune signaling, genetic susceptibility, and stress-related epigenetic changes. Evidence also suggests that biologically defined patient subgroups may benefit from more precise, immune-informed approaches to diagnosis and treatment.

27 Jul 2026

YouTube’s health content rewards attention-grabbing videos over reliable medical information

Researchers analyzed 3,958 Korean-language medical YouTube videos and found that clickbait-heavy content attracted more views, likes, and comments. Higher-quality videos from medical professionals and public institutions often received less attention, highlighting a visibility gap in online health information.

27 Jul 2026

New AI score enhances monitoring of myelodysplastic neoplasms

Weill Cornell Medicine investigators have developed a new AI-based method to assess patients with a form of blood cancer called myelodysplastic neoplasms.

20 Jul 2026

Experts recommend renaming PCOS to better reflect whole-body impacts

A condition affecting approximately 170 million adolescents and women worldwide has a new name – one that better reflects its complexity and far-reaching health impacts.

15 Jul 2026

Lack of awareness and healthcare barriers fuel perimenopause uncertainty

Perimenopause is an underrecognized life stage that is often accompanied by complex and fluctuating symptoms.

15 Jul 2026

New 3D printing technology enables rapid production of personalized contact lenses

A breakthrough combination of new silicone materials and advanced 3D printing technology developed by University of Waterloo researchers could transform how contact lenses are manufactured.

14 Jul 2026

Structural study identifies unexpected cancer-regulating functions of MLL4 protein

The epigenetic modifier MLL4 has an unassuming name-the 4, for instance, indicates it's just one in a family of such modifiers.

13 Jul 2026

Cosmetic microneedles deliver actives where creams struggle

This review shows how microneedle-based cosmetic systems bypass the stratum corneum to deliver poorly penetrating actives, including peptides, retinoids, vitamins, niacinamide, hyaluronic acid, and hair-growth compounds, into viable skin layers.

8 Jul 2026

Beckman Coulter Diagnostics expands Alzheimer’s portfolio with CE-marked p-Tau217 blood test and new high-specificity research assay

Beckman Coulter Diagnostics, a global leader in clinical diagnostics and a Danaher company, today announced it received CE Mark under IVDR for its Access p-Tau217 assay, a blood test designed to support clinical evaluation of amyloid pathology in patients with signs and symptoms of cognitive decline.

7 Jul 2026

ACMG issues guidance for reporting uncertain genetic test variants

The American College of Medical Genetics and Genomics (ACMG) has published a new statement, Points to Consider for the Reporting of Variants of Uncertain Significance in Germline Genetic and Genomic Testing, providing guidance to laboratories and healthcare professionals on the reporting and communication of variants of uncertain significance (VUS) identified through genetic and genomic testing.

1 Jul 2026